mda-mb-468 glutathione content

mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function MDA-MB-468 Xenograft Model - Altogen

Name: mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function MDA-MB-468 Xenograft Model - Altogen
Brand: reganhouse.co.nz
SKU: 1783585555
Price: 21.93 USD
Availability: InStock
Rating: 4.135 (18 reviews)

MDA MB 468 Xenograft Model Altogen Labs MDA MB 468 Luciferase Reporter Cell Line AcceGen Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports MDA MB 231, MDA MB 468 and MCF7 cells show different morphologies in Download Scientific Diagram Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD L1 in Triple Negative Breast Cancer Cells

SKU: 1783585555 · From reganhouse.co.nz

4.1

USD21.93 USD60.93

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Andaloussi, S

J.ChungT

Patent Number: 221279

Research on MOTS-c in ovariectomized mice (a model for postmenopausal metabolic dysfunction) showed reduced fat accumulation in white adipose tissue, increased brown fat activation, and improved insulin sensitivity after just 5 weeks of treatment